• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c-Myc 调控 AML 中 NKG2D 配体 ULBP1/2/3 的表达,并调节它们对 NK 介导的裂解的敏感性。

c-Myc regulates expression of NKG2D ligands ULBP1/2/3 in AML and modulates their susceptibility to NK-mediated lysis.

机构信息

INSERM U753, Insitut Gustave Roussy, Villejuif, France;

Institut Jacques Monod, Centre National de la Recherche Scientifique, Unité Mixte de Recherche, Paris, France;

出版信息

Blood. 2014 Jun 5;123(23):3585-95. doi: 10.1182/blood-2013-11-536219. Epub 2014 Mar 27.

DOI:10.1182/blood-2013-11-536219
PMID:24677544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4198341/
Abstract

Cytarabine (cytosine arabinoside) is one of the most effective drugs for the treatment of patients diagnosed with acute myeloid leukemia (AML). Despite its efficiency against AML cells, the emergence of drug resistance due to prolonged chemotherapy in most patients is still a major obstacle. Several studies have shown that drug resistance mechanisms alter the sensitivity of leukemia cells to immune system effector cells. To investigate this phenomenon, parental acute myeloid cell lines, HL-60 and KG-1, were continuously exposed to increasing doses of cytarabine in order to establish equivalent resistant cell lines, HL-60(R) and KG-1(R). Our data indicate that cytarabine-resistant cells are more susceptible to natural killer (NK)-mediated cell lysis as compared with parental cytarabine-sensitive cells. The increased susceptibility correlates with the induction of UL-16 binding proteins (ULBP) 1/2/3 and NK group 2, member D (NKG2D) ligands on target cells by a mechanism involving c-Myc induction. More importantly, chromatin immunoprecipitation assay revealed that ULBP1/3 are direct targets of c-Myc. Using drug-resistant primary AML blasts as target cells, inhibition of c-Myc resulted in decreased expression of NKG2D ligands and the subsequent impairment of NK cell lysis. This study provides for the first time, the c-Myc dependent regulation of NKG2D ligands in AML.

摘要

阿糖胞苷(胞嘧啶阿拉伯糖苷)是治疗急性髓系白血病(AML)患者最有效的药物之一。尽管它对 AML 细胞有效,但由于大多数患者长期化疗,耐药性的出现仍然是一个主要障碍。多项研究表明,耐药机制改变了白血病细胞对免疫系统效应细胞的敏感性。为了研究这一现象,亲本急性髓系细胞系 HL-60 和 KG-1 连续暴露于递增剂量的阿糖胞苷中,以建立等效的耐药细胞系 HL-60(R) 和 KG-1(R)。我们的数据表明,与亲本阿糖胞苷敏感细胞相比,阿糖胞苷耐药细胞对自然杀伤(NK)介导的细胞裂解更为敏感。这种增加的敏感性与靶细胞上 UL-16 结合蛋白(ULBP)1/2/3 和 NK 组 2,成员 D(NKG2D)配体的诱导相关,该机制涉及 c-Myc 诱导。更重要的是,染色质免疫沉淀分析显示 ULBP1/3 是 c-Myc 的直接靶标。使用耐药性原发性 AML 原始细胞作为靶细胞,抑制 c-Myc 导致 NKG2D 配体的表达减少,随后 NK 细胞裂解受损。这项研究首次提供了 c-Myc 依赖性调节 AML 中 NKG2D 配体的证据。

相似文献

1
c-Myc regulates expression of NKG2D ligands ULBP1/2/3 in AML and modulates their susceptibility to NK-mediated lysis.c-Myc 调控 AML 中 NKG2D 配体 ULBP1/2/3 的表达,并调节它们对 NK 介导的裂解的敏感性。
Blood. 2014 Jun 5;123(23):3585-95. doi: 10.1182/blood-2013-11-536219. Epub 2014 Mar 27.
2
Resistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cells.对阿糖胞苷的耐药性诱导NKG2D配体上调,并增强自然杀伤细胞对白血病细胞的裂解作用。
Neoplasia. 2008 Dec;10(12):1402-10. doi: 10.1593/neo.08972.
3
AML drug resistance: c-Myc comes into play.急性髓系白血病耐药性:c-Myc发挥作用。
Blood. 2014 Jun 5;123(23):3528-30. doi: 10.1182/blood-2014-04-566711.
4
NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities.急性髓系白血病中NKG2D配体的表达在对组蛋白去乙酰化酶抑制剂丙戊酸的反应中增加,并有助于具有单一杀伤细胞免疫球蛋白样受体-人类白细胞抗原I类特异性的自然杀伤细胞系进行同种异体识别。
Blood. 2008 Feb 1;111(3):1428-36. doi: 10.1182/blood-2007-07-101311. Epub 2007 Nov 9.
5
Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition.通过去甲基化剂增加TIMP3表达可减少急性髓系白血病中可溶性MICA、MICB和ULBP2的脱落,促进自然杀伤细胞介导的免疫识别。
Oncotarget. 2017 May 9;8(19):31959-31976. doi: 10.18632/oncotarget.16657.
6
Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications.表达 NKG2D 配体的宫颈癌细胞系能够下调 NKL 细胞上的 NKG2D 受体,具有功能意义。
BMC Immunol. 2012 Feb 8;13:7. doi: 10.1186/1471-2172-13-7.
7
mutants down-regulate AML cell susceptibility to NK-mediated lysis by disruption of the expression of NKG2D ligands, which can be restored by LSD1 inhibition.突变体通过破坏NKG2D配体的表达来下调AML细胞对NK介导的裂解的敏感性,而这种敏感性可通过抑制LSD1得以恢复。
Oncoimmunology. 2022 Jan 5;11(1):2016158. doi: 10.1080/2162402X.2021.2016158. eCollection 2022.
8
NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML.NKG2D 信号传导导致 NK 细胞介导的儿童 AML 细胞溶解。
J Immunol Res. 2015;2015:473175. doi: 10.1155/2015/473175. Epub 2015 Jul 8.
9
Resveratrol sensitized leukemia stem cell-like KG-1a cells to cytokine-induced killer cells-mediated cytolysis through NKG2D ligands and TRAIL receptors.白藜芦醇通过 NKG2D 配体和 TRAIL 受体使白血病干细胞样 KG-1a 细胞对细胞因子诱导的杀伤细胞介导的细胞溶解敏感。
Cancer Biol Ther. 2012 May;13(7):516-26. doi: 10.4161/cbt.19601. Epub 2012 May 1.
10
EGFR inhibitors enhanced the susceptibility to NK cell-mediated lysis of lung cancer cells.表皮生长因子受体抑制剂增强了自然杀伤细胞介导的肺癌细胞裂解的易感性。
J Immunother. 2011 May;34(4):372-81. doi: 10.1097/CJI.0b013e31821b724a.

引用本文的文献

1
Recent Progress and Potential of G4 Ligands in Cancer Immunotherapy.G4配体在癌症免疫治疗中的最新进展与潜力
Molecules. 2025 Apr 17;30(8):1805. doi: 10.3390/molecules30081805.
2
UL16‑binding protein 1 is a significant prognostic and diagnostic marker for breast cancer.UL16结合蛋白1是乳腺癌重要的预后和诊断标志物。
Oncol Lett. 2024 Oct 21;29(1):15. doi: 10.3892/ol.2024.14761. eCollection 2025 Jan.
3
The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer.NKG2D/NKG2D配体系统在癌症中的作用与调控
Biology (Basel). 2023 Aug 2;12(8):1079. doi: 10.3390/biology12081079.
4
NK cell defects: implication in acute myeloid leukemia.自然杀伤细胞缺陷:在急性髓系白血病中的意义。
Front Immunol. 2023 May 9;14:1112059. doi: 10.3389/fimmu.2023.1112059. eCollection 2023.
5
mutants down-regulate AML cell susceptibility to NK-mediated lysis by disruption of the expression of NKG2D ligands, which can be restored by LSD1 inhibition.突变体通过破坏NKG2D配体的表达来下调AML细胞对NK介导的裂解的敏感性,而这种敏感性可通过抑制LSD1得以恢复。
Oncoimmunology. 2022 Jan 5;11(1):2016158. doi: 10.1080/2162402X.2021.2016158. eCollection 2022.
6
Manipulating the NKG2D Receptor-Ligand Axis Using CRISPR: Novel Technologies for Improved Host Immunity.利用 CRISPR 操纵 NKG2D 受体-配体轴:提高宿主免疫的新技术。
Front Immunol. 2021 Aug 12;12:712722. doi: 10.3389/fimmu.2021.712722. eCollection 2021.
7
Leveraging NKG2D Ligands in Immuno-Oncology.利用免疫肿瘤学中的 NKG2D 配体。
Front Immunol. 2021 Jul 29;12:713158. doi: 10.3389/fimmu.2021.713158. eCollection 2021.
8
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.MYC:一种具有预后和治疗意义的多效癌基因,在血液恶性肿瘤中。
J Hematol Oncol. 2021 Aug 9;14(1):121. doi: 10.1186/s13045-021-01111-4.
9
GSK-3α Inhibition in Drug-Resistant CML Cells Promotes Susceptibility to NK Cell-Mediated Lysis in an NKG2D- and NKp30-Dependent Manner.抑制耐药性慢性粒细胞白血病细胞中的GSK-3α以NKG2D和NKp30依赖的方式增强对自然杀伤细胞介导的细胞溶解的敏感性。
Cancers (Basel). 2021 Apr 9;13(8):1802. doi: 10.3390/cancers13081802.
10
Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma.自然杀伤细胞组 2 成员 D 配体在结肠腺癌中的临床意义和前景的研究与验证。
Aging (Albany NY). 2021 Apr 27;13(9):12565-12586. doi: 10.18632/aging.202935.

本文引用的文献

1
Valproic acid upregulates NKG2D ligand expression through an ERK-dependent mechanism and potentially enhances NK cell-mediated lysis of myeloma.丙戊酸通过 ERK 依赖的机制上调 NKG2D 配体的表达,并可能增强 NK 细胞介导的骨髓瘤细胞溶解。
Neoplasia. 2012 Dec;14(12):1178-89. doi: 10.1593/neo.121236.
2
Sense and nonsense of high-dose cytarabine for acute myeloid leukemia.大剂量阿糖胞苷治疗急性髓系白血病的合理与不合理之处。
Blood. 2013 Jan 3;121(1):26-8. doi: 10.1182/blood-2012-07-444851.
3
Drug resistance: still a daunting challenge to the successful treatment of AML.耐药性:仍是成功治疗 AML 的巨大挑战。
Drug Resist Updat. 2012 Feb-Apr;15(1-2):62-9. doi: 10.1016/j.drup.2012.02.001. Epub 2012 Mar 11.
4
Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity.急性髓细胞白血病细胞系 KG1a 中白血病干细胞样细胞对自然杀伤细胞介导的细胞毒性的抵抗作用。
Cancer Lett. 2012 May 28;318(2):173-9. doi: 10.1016/j.canlet.2011.12.017. Epub 2011 Dec 21.
5
Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.人类自然杀伤细胞通过上调 NKG2D 配体 ULBP1 和 ULBP2 而对癌细胞中 p53 的诱导作出反应。
Cancer Res. 2011 Sep 15;71(18):5998-6009. doi: 10.1158/0008-5472.CAN-10-3211. Epub 2011 Jul 15.
6
Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia.在慢性髓性白血病患者中,经 T 细胞耗竭的异基因造血细胞移植后,预防性转移 BCR-ABL、PR1 和 WT1 反应性供体 T 细胞。
Blood. 2011 Jun 30;117(26):7174-84. doi: 10.1182/blood-2010-09-308569. Epub 2011 May 3.
7
Post-transcriptional regulation of ULBP1 ligand for the activating immunoreceptor NKG2D involves 3' untranslated region.ULBP1 配体对激活免疫受体 NKG2D 的转录后调控涉及 3'非翻译区。
Hum Immunol. 2011 Jun;72(6):470-8. doi: 10.1016/j.humimm.2011.03.005. Epub 2011 Mar 13.
8
Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells.STAT3 在 NK 免疫细胞靶向癌细胞上的 MICA 受体的转录调控中的新作用。
Cancer Res. 2011 Mar 1;71(5):1615-26. doi: 10.1158/0008-5472.CAN-09-4540. Epub 2011 Jan 21.
9
NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia.NKAML 研究:一项初步研究,旨在确定亲缘单倍体自然杀伤细胞移植治疗儿童急性髓系白血病的安全性和可行性。
J Clin Oncol. 2010 Feb 20;28(6):955-9. doi: 10.1200/JCO.2009.24.4590. Epub 2010 Jan 19.
10
Acute myelogenous leukemia.急性髓细胞白血病
Exp Hematol. 2009 Jun;37(6):649-58. doi: 10.1016/j.exphem.2009.04.002.